Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 27, 01:22 AM 2012  
MYL WPI MRX PRX AKRX HITK 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for SLXP

Salix story

    
    

Salix Pharmaceuticals Ltd.

 Stock@American Stock Exchange 
United States
    
Use Salix Pharmaceuticals Ltd. story together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.
    
    

The Careerist: Time Inc. Lawyer Writes a Novel


by Anthony Paonita, editor in chief, Corporate Counsel Over after-work drinks at a midtown steakhouse I talked to Helen Wan, an associate general counsel at Time Inc. Wan, who is the primary in-house attorney for Time's lifestyle magazines (think ...

Story Momentum

    
This story from amlawdaily.typepad.com contributed to next trading day price increase. The story delta to the next closing price was 0.56% . The story delta to the current price is 8.55% . story delta up: SLXP
Price
 
Timeline

Similar stores for Salix

    
Few days ago at www.itbusinessnet.com      

Analyst Moves: SLXP, WYNN

IT Business Net - May 10, 2012 By GrabNetworks Salix Pharmaceuticals (SLXP) today had its estimates increased by Jefferies (JEF) after the company beat earnings estimates.
Few days ago at zolmax.com      

Zacks Reiterates Neutral on Salix Pharmaceuticals (SLXP)

Junction Report - May 9, 2012 Salix Pharmaceuticals (NASDAQ: SLXP)'s stock had its ?neutral? rating restated by Zacks in a report issued on Wednesday. They currently have a $55.00 target price on the stock. Auriga Reiterates Hold on Salix Pharmaceuticals (SLXP) - Movie News Guide (blog)
Few days ago at www.streetinsider.com      

Jefferies Boosts Price Target on Salix Pharmaceuticals (SLXP)

StreetInsider.com (subscription) - May 8, 2012 Jefferies analysts raised their price target on Salix Pharmaceuticals (NASDAQ: SLXP) from $54.00 to $63.00 while maintaining a BUY rating on the company.
    
    

Discuss Salix story

       
       
    
Follow Salix News with your standard RSS feed, custom widget, or your favorite social app
Add To Reader
 
Add Salix to your reader
 
Get social with Salix News
 Salix News 
Share Toggle social options for Salix News
    

Salix Research Report

    
    

Market Capitalization Comparison

Market Capitalization is total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting